Regeneron acquired 23andMe for $256M, gaining 15M DNA profiles to enhance R&D. Find out why REGN stock is a Buy.

Man Group plc slashed its stake in Regeneron Pharmaceuticals by over 40%, unloading 24,377 shares in Q4. Despite this selloff, Regeneron’s stock climbed 3.2%, shrugging off investor jitters like a ...

US stocks fell on Tuesday, with the S&P 500 snapping a six-day winning streak as bond yields crept higher, with gloomy comments from JPMorgan's boss dampening the mood.

Japan's bond yield surge hints at global market risks. See how it impacts U.S. Treasuries, the yen, and top investments like ...

Investors burned by President Trump’s trade fight now have to contend with a spending megabill that risks swelling the ...